Abstract

Lung cancer and chronic lung diseases impose major disease burdens worldwide and are caused by inhaled noxious agents including tobacco smoke. The cellular origins of environmental-induced lung tumors and of the dysfunctional airway and alveolar epithelial turnover observed with chronic lung diseases are unknown. To address this, we combined mouse models of genetic labeling and ablation of airway (club) and alveolar cells with exposure to environmental noxious and carcinogenic agents. Club cells are shown to survive KRAS mutations and to form lung tumors after tobacco carcinogen exposure. Increasing numbers of club cells are found in the alveoli with aging and after lung injury, but go undetected since they express alveolar proteins. Ablation of club cells prevents chemical lung tumors and causes alveolar destruction in adult mice. Hence club cells are important in alveolar maintenance and carcinogenesis and may be a therapeutic target against premalignancy and chronic lung disease.

Data availability

All raw data produced in this study are provided as *.xlsx source data Supplements. The microarray data produced by this study were deposited at GEO (http://www.ncbi.nlm.nih.gov/geo/; Accession ID: GSE94981). Previously reported [36-40] murine ATII and human AEC, ATII, AMΦ, non-smokers lung, and LUAD microarray data are available at GEO using Accession IDs GSE82154, GSE55459, GSE46749, GSE18816, and GSE43458).

The following data sets were generated
The following previously published data sets were used

Article and author information

Author details

  1. Magda Spella

    Department of Physiology, University of Patras, Rio, Greece
    For correspondence
    magsp@upatras.gr
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-2505-7778
  2. Ioannis Lilis

    Department of Physiology, University of Patras, Rio, Greece
    Competing interests
    The authors declare that no competing interests exist.
  3. Mario AA Pepe

    Comprehensive Pneumology Center (CPC), Helmholtz Center Munich, Munich, Germany
    Competing interests
    The authors declare that no competing interests exist.
  4. Yuanyuan Chen

    Division of Molecular Thoracic Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany
    Competing interests
    The authors declare that no competing interests exist.
  5. Maria Armaka

    Institute of Immunology, Biomedical Sciences Research Center Alexander Fleming, Vari, Greece
    Competing interests
    The authors declare that no competing interests exist.
  6. Anne-Sophie Lamort

    Comprehensive Pneumology Center (CPC), Helmholtz Center Munich, Munich, Germany
    Competing interests
    The authors declare that no competing interests exist.
  7. Dimitra E Zazara

    Department of Physiology, University of Patras, Rio, Greece
    Competing interests
    The authors declare that no competing interests exist.
  8. Fani Roumelioti

    Institute of Immunology, Biomedical Sciences Research Center Alexander Fleming, Vari, Greece
    Competing interests
    The authors declare that no competing interests exist.
  9. Malamati Vreka

    Department of Physiology, University of Patras, Rio, Greece
    Competing interests
    The authors declare that no competing interests exist.
  10. Nikolaos I Kanellakis

    Department of Physiology, University of Patras, Rio, Greece
    Competing interests
    The authors declare that no competing interests exist.
  11. Darcy E Wagner

    Comprehensive Pneumology Center (CPC), Helmholtz Center Munich, Munich, Germany
    Competing interests
    The authors declare that no competing interests exist.
  12. Anastasios D Giannou

    Department of Physiology, University of Patras, Rio, Greece
    Competing interests
    The authors declare that no competing interests exist.
  13. Vasileios Armenis

    Department of Physiology, University of Patras, Rio, Greece
    Competing interests
    The authors declare that no competing interests exist.
  14. Kristina AM Arendt

    Comprehensive Pneumology Center (CPC), Helmholtz Center Munich, Munich, Germany
    Competing interests
    The authors declare that no competing interests exist.
  15. Laura V Klotz

    Comprehensive Pneumology Center (CPC), Helmholtz Center Munich, Munich, Germany
    Competing interests
    The authors declare that no competing interests exist.
  16. Dimitrios Toumpanakis

    1st Department of Critical Care Medicine and Pulmonary Services, Evangelismos Hospital, Athens, Greece
    Competing interests
    The authors declare that no competing interests exist.
  17. Vassiliki Karavana

    1st Department of Critical Care Medicine and Pulmonary Services, Evangelismos Hospital, Athens, Greece
    Competing interests
    The authors declare that no competing interests exist.
  18. Spyros G Zakynthinos

    1st Department of Critical Care Medicine and Pulmonary Services, Evangelismos Hospital, Athens, Greece
    Competing interests
    The authors declare that no competing interests exist.
  19. Ioanna Giopanou

    Department of Physiology, University of Patras, Rio, Greece
    Competing interests
    The authors declare that no competing interests exist.
  20. Antonia Marazioti

    Department of Physiology, University of Patras, Rio, Greece
    Competing interests
    The authors declare that no competing interests exist.
  21. Vassilis Aidinis

    Institute of Immunology, Biomedical Sciences Research Center Alexander Fleming, Vari, Greece
    Competing interests
    The authors declare that no competing interests exist.
  22. Rocio Sotillo

    Division of Molecular Thoracic Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-0855-7917
  23. Georgios T Stathopoulos

    Department of Physiology, University of Patras, Rio, Greece
    For correspondence
    gstathop@upatras.gr
    Competing interests
    The authors declare that no competing interests exist.

Funding

H2020 European Research Council (260524)

  • Georgios T Stathopoulos

Hellenic State Scholarship Foundation (Post-doctoral Research Fellowship)

  • Magda Spella

Howard Hughes Medical Institute (International Research Scholars Award)

  • Rocio Sotillo

German Center for Lung Research

  • Kristina AM Arendt
  • Laura V Klotz
  • Georgios T Stathopoulos

Hellenic Thoracic Society (PhD Fellowship)

  • Malamati Vreka
  • Anastasios D Giannou

H2020 European Research Council (281614)

  • Rocio Sotillo

H2020 European Research Council (679345)

  • Georgios T Stathopoulos

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: Experiments were designed and approved a priori by the Veterinary Administration of the Prefecture of Western Greece (approval numbers 3741/16.11.2010, 60291/3035/19.03.2012, and 118018/578/30.04.2014) and were conducted according to Directive 2010/63/EU (http://eur-lex.europa.eu/legal-content/EN/TXT/?qid=1486710385917&uri=CELEX:32010L0063).

Human subjects: Archival tissue samples of patients with lung adenocarcinoma were used in this study. The observational protocol for the original studies adhered to the Helsinki Declaration and was approved by the Ethics Committee of the University Hospital of Patras, and all patients gave written informed consent.

Copyright

© 2019, Spella et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 4,630
    views
  • 636
    downloads
  • 47
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Magda Spella
  2. Ioannis Lilis
  3. Mario AA Pepe
  4. Yuanyuan Chen
  5. Maria Armaka
  6. Anne-Sophie Lamort
  7. Dimitra E Zazara
  8. Fani Roumelioti
  9. Malamati Vreka
  10. Nikolaos I Kanellakis
  11. Darcy E Wagner
  12. Anastasios D Giannou
  13. Vasileios Armenis
  14. Kristina AM Arendt
  15. Laura V Klotz
  16. Dimitrios Toumpanakis
  17. Vassiliki Karavana
  18. Spyros G Zakynthinos
  19. Ioanna Giopanou
  20. Antonia Marazioti
  21. Vassilis Aidinis
  22. Rocio Sotillo
  23. Georgios T Stathopoulos
(2019)
Club cells form lung adenocarcinomas and maintain the alveoli of adult mice
eLife 8:e45571.
https://doi.org/10.7554/eLife.45571

Share this article

https://doi.org/10.7554/eLife.45571

Further reading

    1. Biochemistry and Chemical Biology
    2. Cancer Biology
    Vineeth Vengayil, Shreyas Niphadkar ... Sunil Laxman
    Research Article

    Many cells in high glucose repress mitochondrial respiration, as observed in the Crabtree and Warburg effects. Our understanding of biochemical constraints for mitochondrial activation is limited. Using a Saccharomyces cerevisiae screen, we identified the conserved deubiquitinase Ubp3 (Usp10), as necessary for mitochondrial repression. Ubp3 mutants have increased mitochondrial activity despite abundant glucose, along with decreased glycolytic enzymes, and a rewired glucose metabolic network with increased trehalose production. Utilizing ∆ubp3 cells, along with orthogonal approaches, we establish that the high glycolytic flux in glucose continuously consumes free Pi. This restricts mitochondrial access to inorganic phosphate (Pi), and prevents mitochondrial activation. Contrastingly, rewired glucose metabolism with enhanced trehalose production and reduced GAPDH (as in ∆ubp3 cells) restores Pi. This collectively results in increased mitochondrial Pi and derepression, while restricting mitochondrial Pi transport prevents activation. We therefore suggest that glycolytic flux-dependent intracellular Pi budgeting is a key constraint for mitochondrial repression.

    1. Cancer Biology
    2. Genetics and Genomics
    Joakim W Karlsson, Vasu R Sah ... Jonas A Nilsson
    Research Article

    Uveal melanoma (UM) is a rare melanoma originating in the eye’s uvea, with 50% of patients experiencing metastasis predominantly in the liver. In contrast to cutaneous melanoma, there is only a limited effectiveness of combined immune checkpoint therapies, and half of patients with uveal melanoma metastases succumb to disease within 2 years. This study aimed to provide a path toward enhancing immunotherapy efficacy by identifying and functionally validating tumor-reactive T cells in liver metastases of patients with UM. We employed single-cell RNA-seq of biopsies and tumor-infiltrating lymphocytes (TILs) to identify potential tumor-reactive T cells. Patient-derived xenograft (PDX) models of UM metastases were created from patients, and tumor sphere cultures were generated from these models for co-culture with autologous or MART1-specific HLA-matched allogenic TILs. Activated T cells were subjected to TCR-seq, and the TCRs were matched to those found in single-cell sequencing data from biopsies, expanded TILs, and in livers or spleens of PDX models injected with TILs. Our findings revealed that tumor-reactive T cells resided not only among activated and exhausted subsets of T cells, but also in a subset of cytotoxic effector cells. In conclusion, combining single-cell sequencing and functional analysis provides valuable insights into which T cells in UM may be useful for cell therapy amplification and marker selection.